4231.0 25th Anniversary of Alcohol Tobacco & Other Drugs Section / 10th Anniversary of the National Institute on Drug Abuse Clinical Trials Network

Tuesday, November 9, 2010: 2:30 PM - 3:30 PM
Poster
Organizer:
Steven Kritz, MD

Board 1
Evaluating Seeking Safety with Mixed Gender Groups in Community Treatment
Pat Penn, PhD, Amy Tilley, PsyD and Wendy Layne, MA
  
Board 2
Standardizing and streamlining safety reporting in substance abuse trials
Robert Lindblad, MD, Maria Campanella, RN, BSN, CCRA, David Styers, BS, Prasad Kothari, MS, Carmen Rosa, MS and Steven Sparenborg, PhD
Board 3
Partnering to assess characteristics of adults receiving treatment in an urban American Indian health center
Traci Rieckmann, PhD, Carmen Rosa, MS, Roz Ringor-Carty, MSW, Marisa O. Gholson, BA, Lynn Kunkel, MS, CCRP, Steven Gilbert, CADC II, Dennis McCarty, PhD, William E. Lambert, PhD and Birdie Wermy, BA
Board 4
Extended vs. Short-Term Buprenorpine-Naloxone for Opioid Addicted Youth
George Woody, PhD and Sabrina Poole
Board 5
Transporting clinical research to community settings: Implementing Brief Strategic Family Therapy (BSFT) in community substance abuse treatment
Viviana Horigian, MD, Michael Robbins, PhD, Elizabeth Alonso, PhD, Ken Bachrach, PhD, A. Kathleen Burlew, PhD, Ibis Carrion, PsyD, Candace Hodgkins, PhD, Michael Miller, PhD, Nancy Van De Mark, Jessica Ucha, BA and Jose Szapocznik, PhD
Board 6
A community-based, two-phase randomized controlled trial of buprenorphine with and without individual drug counseling for the treatment of opioid analgesic addiction
Scott Provost, MM, MSW, Jennifer Potter, PhD and Roger Weiss, MD
Board 7
Modifying clinical practices in a medication-assisted treatment (MAT) program to the needs of the local patient population
Katharina Wiest, PhD, Dennis McCarty, PhD and Tim Hartnett, MSW, MHA
Board 8
Main study findings from a multi-site CTN trial of OROS-MPH + CBT in adolescents with ADHD and SUD
Paula Riggs, MD, Theresa Winhusen, PhD, Jeff Leimberger, PhD and David Liu, MD
Board 9
Risk behaviors among patients on pharmacotherapies for opioid dependence
Albert Hasson, MSW, Maureen Hillhouse, PhD, Christie Thomas, MPH, Andrew Saxon, MD and Walter Ling, MD
Board 10
Real men are safe
Donald Calsyn, PhD, A. Kathleen Burlew, PhD, Mary Hatch-Maillette, PhD, Lynette Wright, MSW and Jerika Wilson

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Alcohol, Tobacco, and Other Drugs
Endorsed by: American Indian, Alaska Native and Native Hawaiian Caucus

See more of: Alcohol, Tobacco, and Other Drugs
<< Previous Session | Next Session >>